https://www.contemporaryobgyn.net/view/fda-grants-priority-review-to-flibanserin-for-treating-postmenopausal-hsdd
FDA grants Priority Review to flibanserin for treating postmenopausal HSDD
Previous
Previous
FDA Grants Fast Track Designation for Sprout's Flibanserin to Treat HSDD in Postmenopausal Women
Next
Next